BHCCF.US Benchmark Holdings plc

Consumer Defensive Pharmaceuticals USA Stocks
0.3658 USD
Close of Nov 13, 2026
0.3658 0.3658
Market cap
USD 225M
P/E
-
P/B
0.66x
ROE
50.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2025.

Is BHCCF.US undervalued?

Graham number

The Graham number of Benchmark Holdings plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Benchmark Holdings plc fundamental analysis

No fundamental analysis for Benchmark Holdings plc yet.

Benchmark Holdings plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Benchmark Holdings plc

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segme…

Full company profile